The dual antioxidant chitosan oligosaccharides regulate the transdifferentiation of lung effector cells in the management of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. This study investigates the therapeutic potential of chitosan oligosaccharides (COS), a natural carbohydrate with antioxidant properties, in comparison to the FDA-approved drug pirfenidone (PFD). B...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Huan He, Youtao Xu, Xinru Chen, Jiawen Wu, Xianpeng Zhong, Xiyu Li, Jing Qiao
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-06-01
Saila:	Carbohydrate Polymer Technologies and Applications
Gaiak:	Idiopathic pulmonary fibrosis Chitosan oligosaccharides Epithelial‒mesenchymal transition;, Fibroblast‒myofibroblast transition Oxidative stress
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2666893925001203
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!